transdermal technology

Medherant’s Sukhy Nandra, Vasiliki Nikolaou and David Haddleton discuss the benefits and limitations of transdermal drug delivery systems. Read more

, , Opinion

European Pharmaceutical Manufacturer editor, Felicity Thomas, sits down with Sally Waterman, COO at Medherant to discuss the benefits of transdermal drug delivery and how industry developments and changes in patient needs are leading to a shift… Read more

, Opinion

Disruptive drug delivery technology and pharmaceutical cannabinoid molecule development company, CURE Pharmaceutical, expects increased demand for its transdermal drug delivery platform Read more


University of Warwick spin-out company, Medherant, has appointed Laboratoires Plasto Santé to manufacture its drug delivery patches, which will be based on novel transdermal drug delivery technology. Read more